Definitive Contract HT942524C0094
Award Date
9/12/24
Potential Completion Date
9/11/29
Potential Value
$380K
Federal Agency
Defense Health Agency
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
PSC Category
J065 - Maint/Repair/Rebuild Of Equipment- Medical, Dental, And Veterinary Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Illumina, Inc., a leading provider of genetic sequencing and genomic analysis technologies. The contract is for maintenance support, including reagent replacement and remote technical support, for Illumina's iSeq 100 instrument. The contract has a base period plus two option years, with a ceiling value of $4,283.00. There is no set-aside designation for this award. Illumina has been...
This is a firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis equipment. The contract provides for an equipment maintenance agreement on Illumina sequencing systems, such as NextSeq, NovaSeq, MiSeq, and iSeq models, with a ceiling value of $16,198.00 and a performance period ending on December 4, 2025. The contract does...
This federal contract award, valued at $14,562.64, was issued by the Southeast Area of the Department of Defense to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The one-year contract provides for annual preventative maintenance services on Illumina's MiSeq sequencing system. The contract does not have a set-aside designation and is a firm fixed price delivery order. Illumina has previously provided sequencing systems, reagents, and services to...
This is a firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventative maintenance services on Illumina's NextSeq 2000 and NextSeq 500 sequencing systems. The total ceiling value of the contract is $417,372.48 and the ultimate completion date is September 24, 2026. Illumina is a manufacturer of genetic sequencing and genomic analysis instruments and software. This contract does not have a set-aside designation. Illumina has previously...
This is a definitive contract awarded by the Office of Administrative Services Procurement Management Branch, a civilian federal agency, to Illumina, Inc., a leading manufacturer and provider of genetic sequencing and genomic analysis technologies. The contract, valued at $1,093,137.47, is for the maintenance of 15 MiSeq DNA sequencing instruments under the MiSeq Silver Support Plan. The contract is a firm fixed-price agreement with a performance period extending through July 5, 2029. Illumina...
This is a firm fixed-price delivery order awarded by the Midwest Area of a civilian federal agency to Illumina, Inc., a for-profit manufacturer of genetic and genomic analysis instruments and reagents. The contract is for an Illumina Preventive Maintenance Agreement to provide maintenance services for the agency's Illumina sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq models. The contract has a ceiling value of $13,155.45 and a completion date of September 21, 2022. There is no...
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and analytical instruments and reagents. The contract is for maintenance services on an unspecified range of Illumina's sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq models. The contract has a ceiling value of $149,442.60 and an ultimate completion date of September 25, 2017. The contract does not have a set-aside...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc. for an Illumina Service Contract. The contract has a ceiling value of $72,973.00 and a period of performance through February 28, 2026. Illumina, a manufacturer of genomic sequencing and analysis instruments and reagents, will provide maintenance and support services for NIAID's Illumina sequencing systems, including NextSeq,...
This is a firm fixed price delivery order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Illumina, Inc. for $91,615.99. The contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This is not a set-aside contract. Illumina has...
This federal contract award to Illumina, Inc. is for a MiSeQDX Next Generation Sequencing Instrument. The $126,298.10 firm fixed price purchase order was issued by the Defense Health Agency, a defense agency within the Department of Defense. The contract does not have a set-aside designation. Through this award, Illumina will provide the sequencing instrument and associated goods and services to support genomic sequencing and analysis by the agency. Illumina has previously received prime federal...